LXRX
Lexicon Pharmaceuticals Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
Insiders Buying Millions & Millions of Dollars Worth of Stock Trading & Ownership - Lexicon Pharmaceuticals, Inc. * LXRX *
} LXRX { Lexicon Pharmaceuticals, Inc. Insiders Are Buying Buying Millions & Millions of Dollars Worth of Shares. Tremendous Opportunity to Triple Your Money.. Check it out..,,
October's top penny stocks to watch, per insiders
Lexicon Pharmaceuticals director just picked up 1,000,000 shares
I might have what could be both the worst/best investment you can get for the next few months.
Lexicon Pharmaceuticals CEO Lonnel Coats Executes Purchase of 40,000 Shares of Common Stock Shares Rise Premarket
Over $72M bet on these Biotechnology and Fintech Stock? Check out these penny stocks insiders are aggressively buying.
June's penny stock marvels: supercharge your portfolio with these gems!
$LXRX Lexicon pharmaceuticals imminent catalyst JP Morgan Health Conference with NDA
LXRX - Stock doubled when it got its UK approval for diabetes med - on track to be approved in US soon
Mentions
Watching LXRX Whats a good catalyst? Phase 2b Results for Pilavapadin?
Lexicon Pharmaceuticals LXRX. I used to have a “bio stock” policy but this one is different. Full DD I put together with help from the community: https://www.reddit.com/r/LXRXstock/s/2GtCAlxM12
> I have $LXRX This one came up on ToS's option hacker and I made a small entry when it was ~50c back in April. It's doubled. I wish i would have taken a bigger bite. I still think it has room to run and am now averaging up.
LXRX is my big one and I put together the full DD on them below with help from the community. I always had a “no bio stock” policy. But they already have an FDA approved drug and have a big deal “up to” $1 billion with Novo Nordisk so they have major backing. New leadership in place that has turned the ship around fast. I’m also in the camp that they are prepping for buyout which could be big. LXRX DD: https://www.reddit.com/r/LXRXstock/s/n0RyfEfWdz
This is my big one. I put this together with help from the community. Full DD on LXRX: https://www.reddit.com/r/LXRXstock/s/n0RyfEfWdz
I have $LXRX , it hasn’t blown up yet. They’re working on a weightloss pill. Have a deal with novo. But I’m weary to put in too much because it is a biotech
LXRX Lexicon Pharmaceuticals. Full DD that I put together here: https://www.reddit.com/r/LXRXstock/s/qP9zoj9q2b
Full LXRX DD: https://www.reddit.com/r/LXRXstock/s/25r4KUoVlF
Newsmax ! Good lord so many we missed or only made 15% ! I’m in LXRX pretty heavy , she’s my baby ! She a long hold , not everybody is into pharmaceuticals companies! When she hits $10 and beyond I’ll still be here stay blessed, do your DD and remember that ticker LXRX
Full LXRX DD: https://www.reddit.com/r/LXRXstock/s/25r4KUoVlF
LXRX: worst near-term risk scenario is a 30-50% drawdown if trial results are less than ideal. Chance of massive upside in the next 90 days due to anticipated positive trial outcomes. I’m convinced enough to have bought 6000 shares despite being fairly conservative with the rest of my portfolio(GOOG, AMAZON, UBER, UNH, etc). MRVL could also rebound from Friday’s big drop.
LXRX DD: https://www.reddit.com/r/LXRXstock/s/22zecWirfB
Never give up. Stop listening to this sub and dyor. Take your money and invest it in good stocks. ICU SESI SGBX BBAI OSS MDAI RZLV LXRX VOR KSCP.. and the list goes on. Youll see ups and downs but youll be confident and less stressed in holding a bit longer and seeing actual results. Everyone here is waiting for a pump and dump. Get out of the cracked out rat race going on here.. good luck my friend.
AKBA is a must. LAES is a long hold that will retire many many young adults. LXRX is a no brainer BBAI : Been holding for about 6 months. Average cost is $2.90 and I own 25k shares. It's absolutely not too late to get in now. By November 2026, you'll be very happy.
LXRX is on course to receive 1B dollars from Novo. If their weight loss oral pill ultimately gains approval. IXHL could probably be in line for a similar reward. It is a huge market.
Time to pump my 5000 shares of LXRX lmao!
I saved some juice for the party dip on Novo today and LXRX ! LXRX drops to .89 then moon baby moon
My thinking exactly. Sold off 40k shares last week at a loss.. but still better than waiting for r/s. Put my money on SESAI, ICU, LXRX, PSTV. looks like its paying off. SES is about to explode soon, id recoomend keep an eye on it to whoever is reading.
Don’t sleep on LXRX ! Earnings August 6 premarket
I’d be curious your thoughts on Lexicon Pharmaceuticals LXRX. That’s been my play and I’ve doubled my money and then some. I had researched many companies before buying in as it looks like they are setting themselves up for a buyout. Previously I had a “no bio company” rule but this one seemed to be good and has been so far.
What does its drug do? This is an important distinction . If the bottom list hit (and ADIL will imo). They will sky rocket due to the conditions they will alleviate/big population with the issue. LXRX - drug LX9851 - prevent rebound weight gain IHXL - Sleep apnea oral drug. Only one other in test phase exists. ADIL - AD04 - Alcoholism recovery - precision drug. Unlike other AUD - the only drug where full cessation not required during treatment. Which is the toughest part in quitting/recovery process.
He’s saying “ look at all that potential with LXRX stock with the Novo deal pharmaceutical company going parabolic “
I’m in LXRX at .72 so many catalysts. Novo deal up to one billion in revenue , it’s a pharma stock we just met compliance with nasdaq over $1 for ten days any good news and a good earnings report on august 6 should propel us upwards ! I’m not wanting to push a stock heavily. Just letting you know I’m in. I’m in the green and join us if you find potential in it. Stay blessed everybody
LXRX now that compliance is done
$LXRX has been abused a lot, and still quite low .. reddit army assemble haha
I’m up 80% on LXRX. I like it.
Yeah I rode IXHL from 0.56 to .94 and that felt like plenty of profits for me. I'm happy everyone's excited in here for it, I'm trying to focus on steady positive charts for mid-long term holds, been looking at LXRX, looks like it might have what I'm looking for.
Lexicon pharma regained compliance and is ready to fly before earnings #LXRX
LXRX ENVB SKYX are all solid holds. Not NWTG
LXRX degenerates rise up !
IXHL is going places! Also LXRX has been good to me.
No one talking about LXRX??
Yeah. Damn, of all the things to forget… LXRX
We still have growing room on LXRX ! We are up and excited about news coming. All this rise in share price with no news has been phenomenal
No one wanted any part of LXRX months ago ! Up and up we go
Lexicon Pharmaceuticals Inc. $**LXRX** -INPEFA (sotagliflozin) is the only approved dual SGLT1/2 inhibitor for heart failure, positioning Lexicon Pharmaceuticals (LXRX) with a differentiated asset in a market fueled by the world’s rapidly aging population. - Another drug - LX9851 is a first-in-class, oral small molecule inhibitor of Acyl-CoA Synthetase 5 (ACSL5), discovered and developed by Lexicon Pharmaceuticals(Novo rights) represents a non-incretin mechanism with animal data suggesting it might do what others cannot: when combined with semaglutide (Wegovy), it produced deeper weight loss and uniquely prevented weight regain after stopping GLP-1s—one of the central clinical challenges in obesity management. - Novo could offer a unique treatment paradigm—initial weight loss with semaglutide, sustained by adding LX9851 or using LX9851 after GLP-1 cessation—giving it a powerful, exclusive multi-step regimen few rivals could match.
Lexicon Pharmaceuticals inc ($**LXRX**) >INPEFA’s(FDA approved) only-in-class dual mechanism, proven cost-effectiveness, and targeting of an elderly, high-risk population make its profit pipeline compelling and robust—as heart failure and associated comorbidities rise with the aging demographic and as the CHF market grows globally. >Lexicon’s financial reports show early but growing INPEFA sales in the US heart failure market as payer coverage expands, with further potential upside as more robust evidence and new indications (such as hypertrophic cardiomyopathy and chronic kidney disease) are developed. >Global commercialization - Viatris paid $25 million upfront to Lexicon Pharmaceuticals (LXRX) in October 2024 as part of a global licensing agreement for exclusive rights to commercialize sotagliflozin (INPEFA) in all markets outside the US and Europe. >Another drug - LX9851(Novo Nordisk partnership 75m upfront payment with 1B in milestones payments) represents a first-in-class oral, non-incretin mechanism with animal data suggesting it might do what others cannot: when combined with semaglutide (Wegovy), it produced deeper weight loss and uniquely prevented weight regain after stopping GLP-1s—one of the central clinical challenges in obesity management. >Novo could offer a unique treatment paradigm—initial weight loss with semaglutide, sustained by adding LX9851 or using LX9851 after GLP-1 cessation—giving it a powerful, exclusive multi-step regimen few rivals could match.
Is there an analysis for LXRX?
LXRX having a great day. Lets go! >Lexicon’s Genome5000™ program. This is a proprietary genomics-based target discovery platform in which Lexicon scientists systematically studied the function of nearly 5,000 genes to identify more than 100 protein targets with therapeutic potential across various diseases. The Genome5000™ platform uses advanced gene knockout technology to validate targets and accelerate the discovery of innovative medicines. LX9851 and its ACSL5 target were discovered through this genomics-driven approach, demonstrating the platform’s ability to generate novel, high-value drug candidates for major unmet needs. LXRX and Novo Nordisk’s partnership centers on LX9851, a novel obesity drug discovered using Lexicon’s Genome5000™ genomics platform.
Got it - thanks. What is your price target for LXRX?
Hi - Why do you think LXRX is ready to blow up? Whats the catalyst?
LXRX It's primed and ready to blow up, about to regain compliance MVST A bit above your market cap, but it's gonna be huge
LXRX long time holder! Novo nordisk has a billion dollar deal with lexicon, with milestone met they will get the money. Got 75 million up front . It’s been rising with no news ! Any positive news and we going up even more
Thanks for your comment. Looking at LXRX right now. What is your reasoning for the upcoming 100% increase of both of these assets if you wouldn’t mind sharing
Xrp LXRX both about to 100%
If you’re on Robin Hood and want a lottery ticket I’d filter by analyst picks and sort by lowest market cap. I think LXRX has a lot of room to run if you want to just all in on something with 10x potential since they have a novo deal for a glp drug and they’re just over a dollar and I wouldn’t be surprised if they 10x within the next year or so
I talked about LXRX for months yes I’m still here ! I’m still holding a large bag entry at .72 jump in for some fun ! Good entry is a dip to 1.09 otherwise we will be at the mountains
My biggest low priced stock holding. VERY bullish on LXRX.
Holding LXRX $0.5 for 10/17 since 4/28
LXRX, CLYM and ENVB all up good day for biotech
LXRX finally above a dollar today!
Can vouch for LXRX and this poster! My biggest penny stock!
Look up LXRX everything about it says it’s a money maker! So many catalyst, a billion dollar deal with Novo Nordisk ! When milestones are announced we should see a big spike ! It’s a long hold till January 26
Don’t sleep on LXRX ! She’s a long hold pharmaceutical company! Yet when she hits it will be huge
I’m balls deep in LXRX ! I’m green, it’s a pharmaceutical company. It’s a long hold yet when They hit they skyrocket, gotta have some patience with this one
If you got the patience, LXRX is my bet I’m in long have been for 6 months. So many catalyst, billion dollar incentives with milestones met . It’s a pharmaceutical company, they move slow and explode when you least expect it ! Stay blessed
LXRX should make a push over $1+ soon.
Are you still on LXRX Its about to pay off bigtime.
Hoping this is true! > LSEG maintains a current price target of $2.58 for LXRX
LXRX Finally getting the love it deserves
I’m big on another stock LXRX but the people there are very realistic. You can mention concerns and they are heard. No company is perfect. I guess except KULR!
ABCL$ today I beat +14% and reloaded LXRX$ at $0.69
Appreciated thank you! Will check it out. I’m big into LXRX and similarly could be a buyout. And very undervalued IMO.
LXRX has been rebounding and my best stock recently. There are partnerships brewing and/or potential buyout. Check out our subreddit (the one with their logo).
Anyone following $LXRX today? Has a nice little climb today. Up 10%.
🚨Strategic opinion on $LXRX and Novo Nordisk (not financial advice) Lexicon has a deal of up to $1 billion with Novo Nordisk for its therapies (such as LX9851 and Zynquista). 75M have already been paid, but if the milestones are met, Novo will end up paying much more. 💭 From a financial point of view, it might make more sense for Novo to buy Lexicon outright than to continue paying for milestones. ➡️ Why? Full control of the pipeline. Acceleration of development. Long-term savings. They avoid paying up to 1B if they buy now for less. This is not a confirmed rumor, just a strategic reflection based on the agreements already signed. 👉 A takeover bid would not be unreasonable... and perhaps even cheaper than fulfilling the entire agreement.
LXRX showing a good ↗️ tendecy. Worth checking out
No idea what LXRX said but it's going up again
LXRX presenting in an hour up 3% right now. NVVE pumped up but I have no idea why
LXRX volume picking up ahead of their talk at 12:50 est
$LXRX just needs the eyes, solid pipeline billions dollar agreement in the last months. Long on this one.
LXRX waking up, presentation tomorrow
LXRX has been in on going talks for a while. No insider buying and they have been sooooo quiet that something is definitely brewing. Not sure when or what but some news could drop any day.
What are your thoughts on LXRX? I hope we get some news this week from the conference. You think they are setting up for a buyout? They have been very quiet so I think something is brewing.
Please join our subreddit for LXRX lots of good people in there
I’ve had huge returns on AEVA(300%), LASR(100%), and ARBE(70%). LAZR was a bust but I got out just about even (the stock that taught me a lot of the above points). Waiting for LXRX to turn a bigger profit. Watching XENE and a whole bunch of Quantum computing stocks right now.
I’ve had huge returns on AEVA(300%), LASR(100%), and ARBE(70%). LAZR was a bust but I got out just about even(the stock that taught me a lot of the above points). Waiting for LXRX to turn a bigger profit. Watching XENE and a whole bunch of Quantum computing stocks right now.
A possible takeover bid for Lexicon Pharmaceuticals (LXRX) could be reasonable and legal if certain structural, strategic and financial factors exist that justify a buyer (such as Novo Nordisk or another pharmaceutical company) seeing sense in acquiring it. Below I detail the logical, legal and financial reasons that could support this hypothesis: 🧠 LEGAL AND STRATEGIC REASONING OF A POSSIBLE TAKEOVER OF LEXICON 1. ✅ Legality: is a takeover bid viable? Yes, legally any public company can be the subject of a takeover bid if: The buyer offers an attractive premium over the market price. Report to the SEC (in the US) using the Schedule TO form. Meets transparency and fairness requirements (SEC Rule 14d). The approval of the Board of Directors is obtained (if it is a friendly takeover bid) or pressure is applied with a hostile takeover bid if there is resistance. 👉 LXRX does not have public antitakeover clauses or structures with dual voting shares (like Alphabet or Meta), so it is legally vulnerable to a takeover. 2. 🎯 Strategic reasons for a takeover bid A. Undervalued valuable assets LXRX has approved drugs (such as Inpefa) and others in clinical phases, with high potential value in the medium term. The agreement with Novo Nordisk already demonstrates third-party interest in its assets (e.g. LX9851). Its current capitalization (~$250 M) is much lower than the value that its products could generate if they entered the global market. B. Savings in marketing costs A buyer with a global commercial structure (such as Novo or AstraZeneca) could scale Inpefa without duplicating costs, accelerating profits and profitability. C. Synergies Integrating LXRX would allow us to take advantage of clinical data, patents, scientific personnel and development pipelines without starting from scratch. 3. 💰 Financial reasons for a takeover bid A. Affordable purchase price With a market cap of ~$250 M, a takeover bid of $500–600 M ($2–2.50 per share) would be feasible and attractive.
I know this is a big money group not a penny stock group hopefully it doesnt get me banned. Just wanted to throw this out. Im watching closely this biopharma penny stock $LXRX. Trading at 70¢ as we speak. The company has one drug approved waiting for a second one (which both drugs are going to be for heart failure) the one we are waiting is on its 3rd phase. But They recently got a 75 million deal from Novo Norsdisk the creator of ozempic to create another weightloss drug. Analyst think this stock can go up to 6$ a share. Just wanted to share this for you to do your research. This is not financial advise
That’s one of my biggest holdings. LXRX. Check out our new subreddit. Some really smart people in there!
Exton and Granowitz, MD have made it clear they are looking to partner. Artal knows LXRX cannot launch in HCM or pain as evidenced by the sota launch failure. Is it a partnership or acquisition and I thought Pfizer best suited over AZ or Lilly. However, Vertex needs LX9211 for chronic pain. VX-548 is not the answer … no fast track from the fda like lx9211.
GERN ALBA LXRX trust
LXRX slowly but surely getting back to my initial buy price. Keep going, I'm tired of holding this bag!
No idea I'm in LXRX and KULR though